Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 1:16:1646082.
doi: 10.3389/fmicb.2025.1646082. eCollection 2025.

Lab-scale production of postbiotic proteins from Bifidobacterium adolescentis with antiviral and epithelial-protective properties

Affiliations

Lab-scale production of postbiotic proteins from Bifidobacterium adolescentis with antiviral and epithelial-protective properties

María Hernández et al. Front Microbiol. .

Abstract

Postbiotics produced by probiotic bacteria are gaining attention as multifunctional, food-derived agents with potential applications in human and animal health. This study investigates the production and biological activity of protein-rich postbiotics from Bifidobacterium adolescentis, cultivated under controlled conditions in a 3-liter bioreactor as a laboratory-scale model for functional ingredient development. Culture parameters were improved, and one representative batch was selected for biological evaluation. The postbiotic preparation was tested for cytotoxicity using MA104 (renal) and C2BBe1 (intestinal) epithelial cell lines through viability and cell death assays, confirming its safety across a range of concentrations. To assess its functional activity, we evaluated its ability to reduce rotavirus infection and preserve epithelial integrity. The postbiotic significantly reduced viral infectivity and maintained cytoskeletal architecture in infected intestinal cells, supporting its potential protective role. These findings suggest that B. adolescentis-derived postbiotics may serve as safe and biologically active compounds with potential applications in intestinal health and viral infection management.

Keywords: Bifidobacterium adolescentis; antiviral activity; bioreactor; cytoskeletal integrity; functional ingredients; gut epithelium; postbiotics; rotavirus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Three graphs labeled A, B, and C show biomass dry weight over time. (A) depicts growth at different agitation speeds: 50, 100, 150 rpm, and without agitation. (B) compares 5% and 10% inoculum. (C) shows growth in MRS, MRS 1:2, and MRS 1:5. Each graph indicates increases over 54 hours, with variations in growth rate depending on the conditions.
FIGURE 1
Growth kinetics of Bifidobacterium adolescentis under varying microculture conditions. (A) Effect of agitation speed (50, 100, and 150 rpm) on the growth in a 5 mL MRS broth medium under anaerobic conditions, with a 5% inoculum, at 37 °C for 54 h. (B) Effect of inoculum concentration (5% and 10%) on the growth in a 25 mL MRS broth medium under anaerobic conditions, at 37 °C, 150 rpm, over 54 h. (C) Effect of medium concentration (undiluted MRS, 1:2 diluted MRS, and 1:5 diluted MRS) on the growth of in a 25 mL culture under anaerobic conditions, with a 5% inoculum, at 37 °C, 150 rpm, over 54 h. Data points represent the mean from three independent experiments, with error bars indicating standard deviation. Statistical analysis was conducted to assess significant differences between groups, with the appropriate test (parametric or non-parametric) chosen based on data distribution.
Two graphs are shown. (A) A line graph displays biomass dry weight in grams per liter over time in hours, showing an upward trend peaking at 42 hours. (B) Another line graph illustrates the natural log of \( y/y_0 \) over time, with a linear trend line equation \( y = 0.0694x + 0.3286 \) and \( R^2 = 0.9173 \), indicating strong correlation.
FIGURE 2
Growth characterization of Bifidobacterium adolescentis in a lab-scale anaerobic bioreactor. (A) Biomass dry weight (g/L) over time during batch fermentation in a 3 L bioreactor with 1.5 L MRS medium, inoculated at 5% (v/v) and maintained at 37 °C with 200 rpm agitation under anaerobic conditions for 54 h. Data points represent the mean ± standard deviation of three independent measurements. (B) First-order kinetic model fitted to the biomass growth data from panel A. The red dotted line indicates the linear regression trend line, with the corresponding equation and R2 value shown.
(A) Bar chart showing cell viability percentages of MA104 and C2BBe1 cells exposed to varying concentrations of BaP, with a key indicating MA104 cells in blue and C2BBe1 cells in red. (B) Bar chart depicting cell viability for the same cell lines treated with CC, H2O2, and MNTC. (C) Microscopic images displaying CC-treated and BaP-treated MA104 and C2BBe1 cells, highlighting differences in cell morphology. CC, Cell control untreated.
FIGURE 3
Effect of single and multiple doses of BaP on cell viability percentage (MTT colorimetric assay, Abs 540 nm) and morphology in MA104 and C2BBe1 Cells. (A) Effect of a single dose of 14 different concentrations of BaP over 24 h. (B) Effect of repeated administration of BaP at the MNTC every 48 h over 14 days. Each bar represents the mean cell viability percentage from three independent experiments; error bars indicate the standard deviation. Comparisons between CC and BaP MNTC and H2O2 were analyzed using the Mann-Whitney U test at a 95% confidence level. Significance levels are indicated as follows: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. CC, cell control; H2O2, positive control. (C) Photographs of MA104 and C2BBe1 cells, either untreated or treated with BaP at the MNTC, were captured at 100× magnification using an Olympus CKX-41 microscope (Olympus Corporation, Tokyo, Japan) equipped with a Moticam camera and MoticImages software. The images display classic epithelial cells morphology in monolayers and highlight an increase in treated cell clusters.
Bar chart showing cell viability percentages for different treatments measured in micrograms per milliliter. Two treatments, AC and PC, are compared across various concentrations from 250 to 0.03 micrograms per milliliter. Cell viability generally exceeds 100 percent, except for H2O2, which is significantly lower. Error bars indicate variability, and asterisks denote statistical significance.
FIGURE 4
Effect of single doses of 14 different protein concentrations from an Abiotic Control (AC, dark blue) and a Production Control (PC, light blue) on cell viability percentage in MA104 cells, as measured by the MTT colorimetric assay (Abs 540 nm). Each bar represents the mean percentage of cell viability from three independent experiments, with error bars indicating standard deviation. Data were analyzed using an independent samples Mann–Whitney U test. Differences between the evaluated concentrations and the cell control (CC) were significant. Significance levels are indicated as follows: **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. The cell control (CC) corresponds to untreated cells in medium without FBS.
Two box plots labeled A and B compare treatments on MA104 and C2BBe1 cells. Plot A (Annexin V-FITC, RFU) shows higher values for C2BBe1 cells with a significant increase in the MNTC treatment. Plot B (PI, RFU) shows similar distributions between treatments without significant differences. Blue represents MA104 cells, and red represents C2BBe1 cells.
FIGURE 5
Evaluation of cell death markers in MA104 and C2BBe1 cells after BaP MNTC exposure. Evaluation of cell death markers following exposure to BaP MNTC in MA104 (blue boxes) and C2BBe1 (red boxes) cells for 8 days every 48 h and medium was partially refreshed at each point. (A) Phosphatidylserine translocation assessed using Annexin V-FITC (488 nm filter). (B) DNA fragmentation evaluated using propidium iodide (PI) fluorochrome (617 nm filter). Boxes represent the mean and interquartile range from three independent experiments with BaP MNTC exposure. Whiskers indicate the maximum and minimum values. Comparisons between the cell control (CC) and BaP MNTC were analyzed using Student’s t-test at a 95% confidence level. Significance levels are indicated as follows: *p ≤ 0.05. CC, cell control; H2O2 positive control.
Three bar graphs labeled (A), (B), and (C) show the viral infectivity (%) against different concentrations of BaP, AC, and PC in micrograms per milliliter, respectively. Graph (A) shows a significant decrease in viral infectivity at 250 µg/mL BaP. Graph (B) shows little change in viral infectivity across AC concentrations. Graph (C) presents a notable decrease in viral infectivity at 250 µg/mL PC. Statistical significance is indicated by asterisks, with triple asterisks (***) representing higher significance.
FIGURE 6
In vitro anti-rotavirus activity in MA104 Cells. Rhesus rotavirus (RRV) was co-incubated with two concentrations of (A) BaP, (B) AC, and (C) PC for 1 h at 37°C. MA104 cells were subsequently exposed to the BaP/AC/PC-RRV mixture and incubated for an additional 9 h. Viral infection levels were quantified using immunofluorescence to measure FFU/mL, with infection percentages calculated relative to the positive infection control (RRV). The scatter plot displays mean values with error bars representing standard deviation from three independent samples. Comparisons between the infection positive control (RRV) and BaP treatments were analyzed using Student’s t-test at a 95% confidence level, with significance levels indicated as follows: *p ≤ 0.05, ***p ≤ 0.001. RRV, infection positive control; MOCK, uninfected control. Photographs were captured using an Olympus CKX-41 inverted microscope (Olympus Corporation, Tokyo, Japan) equipped with a Lumin Epi-Fluorescence Module and a Moticam camera with MoticImages software, at 100× magnification. The images display Fluorescent Focus Units (FFU) in green, representing RRV-infected cells.
Fluorescence microscopy images show cells treated under different conditions at two time points, six and nine hours post-infection (hpi). The conditions include a control (MOCK), treatment with RRV alone, and RRV with BaP at concentrations of 125 and 250 micrograms per milliliter. Red rectangles highlight areas of interest within each panel.
FIGURE 7
Effect of BaP at MNTC and half-maximal concentration on cytoskeletal architecture in RV-Infected C2BBe1 cells at 6 and 9 hpi. Photomicrographs display cell morphology and distribution in uninfected control cells (MOCK), infected untreated control cells (+RRV), and each BaP treatment condition. Green fluorescence (F-actin) indicates cytoskeletal organization. Red boxes highlight representative areas where morphological changes and differences in F-actin organization are most evident.

References

    1. Abdulqadir R., Engers J., Al-Sadi R. (2023). Role of bifidobacterium in modulating the intestinal epithelial tight junction barrier: Current knowledge and perspectives. Curr. Dev. Nutr. 7:102026. 10.1016/j.cdnut.2023.102026 - DOI - PMC - PubMed
    1. Aguilar-Toalá J. E., Garcia-Varela R., Garcia H. S., Mata-Haro V., González-Córdova A. F., Vallejo-Cordoba B., et al. (2018). Postbiotics: An evolving term within the functional foods field. Trends Food Sci. Technol. 75 105–114. 10.1016/j.tifs.2018.03.009 - DOI
    1. Allen S. J., Martinez E. G., Gregorio G. V., Dans L. F. (2010). Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010:Cd003048. 10.1002/14651858.CD003048.pub3 - DOI - PMC - PubMed
    1. Armah G. E., Sow S. O., Breiman R. F., Dallas M. J., Tapia M. D., Feikin D. R., et al. (2010). Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 376 606–614. 10.1016/S0140-6736(10)60889-6 - DOI - PubMed
    1. Arnaud J. P., Lacroix C., Foussereau C., Choplin L. (1993). Shear stress effects on growth and activity of Lactobacillus delbrueckii subsp. bulgaricus. J. Biotechnol. 29 157–175. 10.1016/0168-1656(93)90048-r - DOI - PubMed

LinkOut - more resources